C-erbB-2 gene amplification as a prognostic marker in human bladder cancer

Hiroshi Miyamoto, Yoshinobu Kubota, Sumio Noguchi, Kazunori Takase, Junichi Matsuzaki, Masatoshi Moriyama, Shigeo Takebayashi, Hitoshi Kitamura, Masahiko Hosaka

Research output: Contribution to journalArticle


Objectives. To evaluate c-erbB-2 gene amplification and its prognostic significance in transitional cell carcinoma of the bladder. Methods. Alterations in the gene copy number of c-erbB-2 were detected in 57 bladder tumor samples using a method based on the polymerase chain reaction. Results. Eighteen tumors (32%) showed gene amplification of c-erbB-2, which correlated with tumor grade and stage. A strong association of c-erbB-2 amplification with patient survival was also found. The amplification resulted in a significantly poorer prognosis among the patients with high-grade and/or invasive tumors. Multivariate analysis revealed that c-erbB-2 amplification and tumor grade were independent prognostic factors. Conclusions. Our data indicate a possible role of the c-erbB-2 gene in the development of aggressive behavior in bladder tumors. Moreover, the use of c-erbB-2 gene amplification, together with tumor grade and stage, could provide an accurate basis for determining the prognosis of bladder cancer.

Original languageEnglish (US)
Pages (from-to)679-683
Number of pages5
Issue number5
StatePublished - Jan 1 2000


ASJC Scopus subject areas

  • Urology

Cite this

Miyamoto, H., Kubota, Y., Noguchi, S., Takase, K., Matsuzaki, J., Moriyama, M., Takebayashi, S., Kitamura, H., & Hosaka, M. (2000). C-erbB-2 gene amplification as a prognostic marker in human bladder cancer. Urology, 55(5), 679-683. https://doi.org/10.1016/S0090-4295(99)00604-4